J. Donald Payne
President and CEO, Director
Mr. Payne has been the CEO from the commencement of operations in 2002. He has 30 years of progressively senior management experience including prior executive roles at Life Cell, Sensus Drug Development, and Aprogenex. He holds an MBA from Rice University and a BBA from Texas A&M.

Glenn P. Goodrich, PhD
Director, Process Development and Chemistry
Dr. Goodrich has been with Nanospectra since 2005.  He holds a BS in Chemistry and a BA in Computer Science from The University of Iowa and a PhD in Chemistry from Penn State University.  He has extensive experience with fabrication and application of nanoparticles, having worked in the field in graduate school and as a post-doctoral fellow under Dr. Naomi Halas at Rice University.

Board of Directors

J. Donald Payne
Director
President and CEO, Nanospectra Biosciences, Inc.

David Anderson
Chairman of the Board of Directors
President and CEO, MithraGen, Inc.
Former COO, Tanox Inc.

Patrick W. Pace, MD
Director
Director, Citadel Securities

Jennifer West, PhD
Director and Co-Founder
Professor & Chairperson, Department of Bioengineering, Rice University

Ron Zimmerman
Director
President and CEO, PLx Pharma